204 related articles for article (PubMed ID: 2754719)
1. Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.
van den Broek LA; Lázaro E; Zylicz Z; Fennis PJ; Missler FA; Lelieveld P; Garzotto M; Wagener DJ; Ballesta JP; Ottenheijm HC
J Med Chem; 1989 Aug; 32(8):2002-15. PubMed ID: 2754719
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth.
van den Broek LA; Liskamp RM; Colstee JH; Lelieveld P; Remacha M; Vázquez D; Ballesta JP; Ottenheijm HC
J Med Chem; 1987 Feb; 30(2):325-33. PubMed ID: 3543365
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of sparsomycin analogues.
Duke SS; Boots MR
J Med Chem; 1983 Nov; 26(11):1556-61. PubMed ID: 6415284
[TBL] [Abstract][Full Text] [Related]
4. Sparsomycin analogs. VI. Synthesis and antitumor activity of octylsparsomycin analogs.
Kanatomo S; Hase T; Wada A; Ohki K; Nagai S; Tanaka M; Sasaki T
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):688-91. PubMed ID: 2752478
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of sparsomycin and its analogues. Octylsparsomycin: the first analogue more active than sparsomycin.
Liskamp RM; Colstee JH; Ottenheijm HC; Lelieveld P; Akkerman W
J Med Chem; 1984 Mar; 27(3):301-6. PubMed ID: 6699875
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of sparsomycin analogs as potential antitumor agents.
Dubois RJ; Lin CC; Michel BL
J Pharm Sci; 1975 May; 64(5):825-9. PubMed ID: 1151655
[TBL] [Abstract][Full Text] [Related]
7. The development of sparsomycin as an anti-tumour drug.
Ottenheijm HC; van den Broek LA
Anticancer Drug Des; 1988 Mar; 2(4):333-7. PubMed ID: 3365303
[TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.
Zylicz Z; Wagener DJ; van Rennes H; van der Kleijn E; Lelieveld P; van den Broek LA; Ottenheijm HC
Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941
[TBL] [Abstract][Full Text] [Related]
9. Pyrimidinylpropenamides as antitumor agents. Analogues of the antibiotic sparsomycin.
Lin CC; Dubois RJ
J Med Chem; 1977 Mar; 20(3):337-41. PubMed ID: 845865
[TBL] [Abstract][Full Text] [Related]
10. Importance of the hydrophobic sulfoxide substituent on nontoxic analogs of sparsomycin.
Ash RJ; Fite LD; Beight DW; Flynn GA
Antimicrob Agents Chemother; 1984 Apr; 25(4):443-5. PubMed ID: 6375553
[TBL] [Abstract][Full Text] [Related]
11. The chiral synthesis and biochemical properties of electron rich phenolic sulfoxide analogs of sparsomycin.
Flynn GA; Ash RJ
Biochem Biophys Res Commun; 1990 Jan; 166(2):673-80. PubMed ID: 2405852
[TBL] [Abstract][Full Text] [Related]
12. Effect of sparsomycin analogues on the puromycin-peptidyl transferase reaction on ribosomes.
Lee CK; Vince R
J Med Chem; 1978 Feb; 21(2):176-9. PubMed ID: 340693
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of sparsomycin: modification at the hydroxyl group.
Lázaro E; van den Broek LA; Ottenheijm HC; Lelieveld P; Ballesta JP
Biochimie; 1987 Aug; 69(8):849-56. PubMed ID: 3122847
[TBL] [Abstract][Full Text] [Related]
14. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
Kallia-Raftopoulos S; Synetos D; Ottenheijm HC; van den Broek LA; Coutsogeorgopoulos C
Mol Pharmacol; 1996 Jun; 49(6):1085-91. PubMed ID: 8649347
[TBL] [Abstract][Full Text] [Related]
15. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
[TBL] [Abstract][Full Text] [Related]
16. Sparsomycin analogs. V. Synthesis and antitumor activity of (E)-beta-(pyrimidin-5-yl)acrylamides.
Kanatomo S; Wada A; Hamaoka Y; Nagai S; Fukuda S; Tanaka M; Sasaki T
Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4421-5. PubMed ID: 3246010
[No Abstract] [Full Text] [Related]
17. Sparsomycin analogs. II. Synthesis and biological activities of 5-carboxy-6-methyluracil derivatives.
Kanatomo S; Nagai S; Hase T; Ohki K; Nomura C; Okezaki E
Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):135-43. PubMed ID: 6850930
[No Abstract] [Full Text] [Related]
18. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of cisplatin antitumor activity on L1210 leukemia s.c. by sparsomycin and three of its analogues.
Zylicz Z; Hofs HP; Wagener DJ
Cancer Lett; 1989 Jul; 46(2):153-7. PubMed ID: 2752385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
